Objective
To assess the prevalence, patterns, and associated factors of glomerulonephritis among patients presenting with clinical features suggestive of the disease at Mbarara Regional Referral Hospital (MRRH) in Southwestern Uganda.
Overview of Infection-Related Glomerulonephritis
Infection-related glomerulonephritis (IRGN) is an immune-mediated injury of the glomeruli that occurs either during an active infection or after a variable latent period. Poststreptococcal glomerulonephritis (PSGN) represents the classic form of IRGN, with key pathogenic roles attributed to streptococcal antigens such as the nephritis-associated plasmin receptor and streptococcal exotoxin B. While PSGN is more common in children, adult cases are frequently associated with other pathogens, including staphylococcal bacteria, hepatitis C virus, and human immunodeficiency virus (HIV), and less commonly, parasitic infections.
Management is largely supportive, although targeted antimicrobial or antiviral therapy is indicated when an active infection persists. PSGN is generally self-limiting with favorable outcomes, whereas other forms of IRGN may lead to significant morbidity and long-term renal complications. There is a need for more epidemiological studies to better understand the global burden and to guide prevention and treatment strategies.
HIV-Associated Kidney Disease
HIV-associated nephropathy (HIVAN) is a leading cause of chronic kidney disease (CKD) among individuals infected with HIV-1, particularly in populations of African descent. This susceptibility is linked to genetic variations in the APOL1 gene. HIVAN typically progresses rapidly to end-stage renal disease (ESRD) if untreated and is characterized histologically by focal segmental glomerulosclerosis (often collapsing type) and tubular microcystic changes.
In addition to HIVAN, individuals with HIV may develop other renal pathologies, including diabetic nephropathy, immune-complex glomerulonephritis, membranous nephropathy, and amyloidosis. These conditions can mimic HIVAN but require distinct management approaches. Evidence from randomized trials indicates that highly active antiretroviral therapy (HAART) significantly improves renal outcomes, particularly when initiated early.
Clinical Features and Prognosis of Poststreptococcal GN
The exact nephritogenic streptococcal antigen remains uncertain. Kidney biopsy is generally reserved for atypical cases or when prognosis is unclear. Histologically, PSGN presents as acute endocapillary glomerulonephritis with immune complex deposition.
Clinical manifestations of acute nephritic syndrome typically resolve within two weeks. Severe complications such as massive proteinuria or rapidly progressive glomerulonephritis are rare. Complement levels usually normalize within 8–10 weeks; persistent hypocomplementemia may warrant further investigation, including biopsy.
The short-term prognosis is excellent in children, though mortality rates in elderly patients can be significant. Long-term outcomes are generally favorable, with low progression to ESRD, except in older individuals with persistent proteinuria. Antibiotics are useful in eradicating infection but have limited impact on reversing established glomerular injury.
Epidemiological Shifts in IRGN
Historically, IRGN predominantly affected children following streptococcal infections. However, over recent decades, there has been a shift toward adult populations, particularly the elderly and immunocompromised. In adults, infections are often ongoing at diagnosis, and causative organisms are more diverse, with staphylococci being prominent. Outcomes in adults are generally less favorable compared to children.
Global and Regional Burden of GN
End-stage renal disease poses a major global health challenge, especially in low-resource settings where access to renal replacement therapy is limited. In developed countries, diabetes and hypertension are the leading causes of ESRD, whereas glomerulonephritis plays a more prominent role in developing regions.
In Africa, glomerular diseases account for a substantial proportion of ESRD cases, ranging from 10% to 52%. However, limited diagnostic infrastructure, scarcity of renal registries, and inadequate biopsy services hinder accurate characterization of disease patterns.
Clinical Patterns and Risk Factors
Glomerulonephritis presents in various clinical forms, including acute nephritic syndrome, chronic glomerulonephritis, nephrotic syndrome, and rapidly progressive glomerulonephritis. These conditions may arise from infections, autoimmune diseases, genetic predisposition, or environmental exposures.
Common symptoms include hematuria, proteinuria, edema, hypertension, and reduced kidney function. Risk factors such as poor sanitation, infections, obesity, smoking, and high salt intake contribute to disease occurrence and progression.
Diagnosis and Classification
Diagnosis involves urine analysis, blood tests, serological investigations, and ultimately kidney biopsy, which remains the gold standard. Histological patterns vary widely and may include proliferative, membranoproliferative, crescentic, or sclerosing forms.
Modern classification emphasizes identifying the underlying cause rather than relying solely on histological patterns. Categories include immune-complex glomerulonephritis, ANCA-associated vasculitis, anti-glomerular basement membrane disease, and complement-mediated disorders.
Conclusion
Glomerulonephritis encompasses a diverse group of kidney disorders with varying causes, presentations, and outcomes. Despite advances in understanding its pathogenesis and management, significant gaps remain, particularly in resource-limited settings. Strengthening diagnostic capacity and conducting epidemiological studies are essential for improving prevention, early detection, and treatment strategies.
